Financial Performance - The company's operating revenue primarily comes from the rubber processing industry, including PVC pipes, profiles, sheets, and wires, which are affected by domestic and international economic conditions [6]. - The company's operating revenue for the first half of 2023 was approximately ¥1.23 billion, a decrease of 16.13% compared to ¥1.47 billion in the same period last year [36]. - The net profit attributable to shareholders was approximately ¥58.39 million, down 55.17% from ¥130.25 million year-on-year [36]. - The net profit after deducting non-recurring gains and losses was approximately ¥45.13 million, a decline of 66.70% compared to ¥135.52 million in the previous year [36]. - The net cash flow from operating activities was approximately ¥23.25 million, a significant drop of 77.34% from ¥102.61 million in the same period last year [36]. - The total assets at the end of the reporting period were approximately ¥3.38 billion, an increase of 10.82% from ¥3.05 billion at the end of the previous year [36]. - The basic earnings per share for the reporting period were ¥0.12, down 57.14% from ¥0.28 in the same period last year [36]. - The diluted earnings per share were also ¥0.12, reflecting the same percentage decrease of 57.14% compared to the previous year [36]. - The weighted average return on net assets was 2.29%, a decrease of 3.08% from 5.37% in the previous year [36]. - The company's revenue for the reporting period was ¥1,231,972,887.65, a decrease of 16.13% compared to the same period last year [51]. Market Conditions and Risks - In the first half of 2023, the total profit of national industrial enterprises decreased by 16.8%, with the chemical raw materials and chemical products manufacturing industry declining by 52.2% [6]. - The company faces risks of declining gross profit margins due to intensified competition and potential price reductions by competitors in the plastic processing industry [7]. - The overall economic environment remains uncertain, which may impact the company's future performance and strategic decisions [6]. - The company is exposed to risks from fluctuations in raw material prices, which could affect production costs and profit margins [16]. - The company is facing risks of declining gross profit margins due to intensified competition and shrinking domestic demand since the second half of 2022 [110]. - The company is also facing risks related to potential oversupply in the plastic processing and rubber processing industries if demand does not meet expectations [113]. Investment and Projects - The company is investing in several new projects, including a 330,000-ton high polymer new materials project and a 200,000-ton caustic soda technology renovation project, which carry risks related to market demand and technological changes [9]. - The company anticipates that the new projects will enhance revenue and profitability, but there are uncertainties regarding the actual operational performance and market conditions [10]. - New project investments include a 330,000-ton high polymer new materials project and a 200,000-ton ACM device project, which carry risks related to actual operating conditions not meeting expectations [111]. - The company aims to enhance product performance and application space for green building materials through ongoing R&D and strategic acquisitions [53]. - The company has committed to purchasing all equity of the project joint venture held by Rike Chemical if the first phase project does not commence production within 18 months from obtaining the construction permit [141]. Research and Development - The company's R&D investment increased by 17.51% to ¥21.85 million, reflecting a commitment to enhancing technological capabilities [65]. - Research and development expenses have increased by 15%, totaling 30 million RMB, to support innovation and new technology [140]. - The company holds 33 invention patents, including 4 foreign patents, and 36 utility model patents, underscoring its focus on innovation [61]. Human Resources and Management - The company is experiencing a shortage of skilled human resources, which may impact the progress of new projects [11]. - The company plans to maintain a focus on cost optimization, technological innovation, and new product development to mitigate risks associated with declining profit margins [7]. - The company is addressing human resource shortages as it expands, which could impact the progress of new projects [112]. Environmental and Social Responsibility - The company emphasizes environmental protection and has implemented measures to treat major pollutants such as volatile organic compounds and wastewater, ensuring compliance with local standards [130]. - The company has established a comprehensive environmental management system to continuously improve and maintain its environmental protection facilities [135]. - The company actively participates in social responsibility initiatives and engages in public welfare activities, aligning with national policies [136]. - Environmental compliance is critical, as the company produces waste during manufacturing; it will continue to invest in eco-friendly practices to meet regulatory standards [118]. Shareholder and Corporate Governance - The company will not distribute cash dividends or issue bonus shares for the reporting period [17]. - The company prioritizes the protection of shareholder rights, particularly for minority shareholders, by enhancing corporate governance and internal control systems [132]. - The company has committed to maintaining the legal rights of shareholders and ensuring no unfair benefits are provided to other entities [139]. - The company has pledged to publish accurate and timely periodic reports and disclose significant information affecting investors, adhering to regulatory oversight [139].

| 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 | | --- | | 记载、误导性陈述或重大遗漏。 | 山东日科化学股份有限公司（以下简称"公司"）于 2023 年 8 月 21 日收到 深圳证券交易所上市审核中心（以下简称"上市审核中心"）出具的《关于山东 日科化学股份有限公司申请向不特定对象发行可转换公司债券的审核问询函》 （审核函〔2023〕020127 号）（以下简称"《审核问询函》"），上市审核中心对公 司提交的向不特定对象发行可转换公司债券的申请文件进行了审核，并形成了审 核问询问题。 公司将按照上述《审核问询函》的要求，会同相关中介机构逐项落实《审核 问询函》问题并及时提交对《审核问询函》的回复，回复的内容将通过临时公告 方式予以披露，并在披露后通过深圳证券交易所发行上市审核业务系统报送相关 文件。 山东日科化学股份有限公司 关于收到深圳证券交易所《关于山东日科化学股份有限公司申 请向不特定对象发行可转换公司债券的审核问询函》的公告 公司本次向不特定对象发行可转换公司债券事项尚需通过深圳证券交易所 审核，并获得中国证券监督管理委员会作出同意注册的决定后方可实施，最终能 ...

山东日科化学股份有限公司 二〇二〇年度财务报表 审计报告 目 录 永拓会计师事务所(特殊普通合伙) 6-1-1 一、审计报告 二、财务报表 1. 2020年12月31日合并资产负债表及母公司资产负债表 2. 2020年度合并利润表及母公司利润表 3. 2020年度合并现金流量表及母公司现金流量表 4. 2020年度合并所有者权益变动表及母公司所有者权益变 动表 5. 2020年度财务报表附注 拓会计师事务所(特殊普通合伙) tuo Certified Public Accountants 审计报告 永证审字(2021)第 110002 号 山东日科化学股份有限公司全体股东: 一、审计意见 我们审计了山东日科化学股份有限公司(以下简称"日科化学")合并及母 公司财务报表,包括2020年12月31日的合并资产负债表和母公司资产负债表, 2020年度的合并利润表和母公司利润表、合并现金流量表和母公司现金流量表、 合并股东权益变动表和母公司股东权益变动表以及相关财务报表附注。 我们认为,后附的财务报表在所有重大方面按照企业会计准则的规定编制, 公允反映了日科化学 2020年12月31日的合并及母公司财务状况以及 20 ...

中泰证券股份有限公司 关于 山东日科化学股份有限公司 向不特定对象发行可转换公司债券 之 上市保荐书 （申报稿） 保荐机构（主承销商） （济南市市中区经七路 86 号） 二零二三年七月 山东日科化学股份有限公司 上市保荐书 保荐机构及保荐代表人声明 中泰证券股份有限公司（以下简称"中泰证券"、"保荐机构"或"本保荐 机构"）接受山东日科化学股份有限公司（以下简称"公司"、"发行人"或"日 科化学"）的委托，担任其向不特定对象发行可转换公司债券项目的保荐机构， 并指定赵怡西、李志斌担任本次保荐工作的保荐代表人。 中泰证券及其保荐代表人根据《中华人民共和国公司法》（以下简称"《公 司法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、《上市 公司证券发行注册管理办法》（以下简称"《发行注册管理办法》"）、《证券 发行上市保荐业务管理办法》等有关法律、法规和中国证监会、深圳证券交易所 的有关规定，诚实守信，勤勉尽责，严格按照依法制订的业务规则、行业执业规 范和道德准则出具本上市保荐书，并保证所出具文件的真实性、准确性和完整性。 若因保荐机构为发行人本次发行制作、出具的文件有虚假记载、误导性陈述或者 重大遗 ...

山东日科化学股份有限公司 Shandong Rike Chemical Co.,LTD. （山东省昌乐县英轩街 3999 号） 向不特定对象发行可转换公司债券 募集说明书 （申报稿） 保荐机构（主承销商） （济南市市中区经七路 86 号） 二〇二三年七月 股票简称：日科化学 股票代码：300214 山东日科化学股份有限公司 向不特定对象发行可转换公司债券募集说明书 声明 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对申请 文件及所披露信息的真实性、准确性、完整性作出保证，也不表明其对发行人的 盈利能力、投资价值或者对投资者的收益作出实质性判断或保证。任何与之相反 的声明均属虚假不实陈述。 根据《证券法》的规定，证券依法发行后，发行人经营与收益的变化，由发 行人自行负责。投资者自主判断发行人的投资价值，自主作出投资决策，自行承 担证券依法发行后因发行人经营与收益变化或者证券价格变动引致的投资风险。 1-1-1 山东日科化学股份有限公司 向不特定对象发行可转换公司债券募集说明书 五、向不特定对象发行可转换公司债券摊薄即期回报对公司主要财务 指标影响的提示 重大事项提示 公司特别提示投资者对下列重大 ...

证券代码：300214 证券简称：日科化学 公告编号：2023-037 山东日科化学股份有限公司 公司本次向不特定对象发行可转换公司债券事项尚需通过深交所审核，并获 得中国证券监督管理委员会作出同意注册的决定后方可实施，最终能否通过深交 所审核，并获得中国证券监督管理委员会作出同意注册的决定及其时间尚存在不 确定性。公司将根据该事项的审核进展情况及时履行信息披露义务，敬请广大投 资者注意投资风险。 特此公告。 山东日科化学股份有限公司 董 事 会 二〇二三年八月九日 关于向不特定对象发行可转换公司债券申请 获得深圳证券交易所受理的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 山东日科化学股份有限公司（以下简称"公司"） 于 2023 年 8 月 8 日收到 深圳证券交易所（以下简称"深交所"）出具的《关于受理山东日科化学股份有 限公司向不特定对象发行可转换公司债券申请文件的通知》（深证上审〔2023〕 611 号），深交所对公司报送的向不特定对象发行可转换公司债券募集说明书及 相关申请文件进行了核对，认为申请文件齐备，决定予以受理。 ...

山东德衡律师事务所 关于 向不特定对象发行可转换公司债券的 山东日科化学股份有限公司 法律意见书 二零二三年七月 4-1-1 | | | | 目 | 录 | 2 | | --- | --- | --- | | 正 | 文 | 4 | | 一、 | 本次发行的批准和授权 | 4 | | 二、 | 本次发行的主体资格 | 4 | | 三、 | 本次发行的实质条件 | 4 | | 四、 | 发行人的设立 | 9 | | 五、 | 发行人的独立性 | 9 | | 六、 | 发行人的主要股东、实际控制人 | 9 | | 七、 | 发行人的股本及演变 | 11 | | 八、 | 发行人的业务 | 11 | | 九、 | 关联交易及同业竞争 | 13 | | 十、 | 发行人的主要资产 | 13 | | 十一、 | 发行人的重大债权债务 | 15 | | 十二、 | 发行人的重大资产变化及收购兼并 | 15 | | 十三、 | 发行人公司章程的制定与修改 | 15 | | 十四、 | 发行人的股东大会、董事会、监事会议事规则及规范运作 15 | | | 十五、 | 发行人董事、监事和高级管理人员及其变化 16 | | | ...

中泰证券股份有限公司 关于 山东日科化学股份有限公司 向不特定对象发行可转换公司债券 之 发行保荐书 （申报稿） 保荐机构（主承销商） （济南市市中区经七路 86 号） 二零二三年七月 山东日科化学股份有限公司 证券发行保荐书 保荐机构及保荐代表人声明 中泰证券股份有限公司（以下简称"中泰证券"、"保荐机构"或"本保荐机 构"）接受山东日科化学股份有限公司（以下简称"公司"、"发行人"或"日科 化学"）的委托，担任其向不特定对象发行可转换公司债券项目的保荐机构，并 指定赵怡西、李志斌担任本次保荐工作的保荐代表人，特此向深圳证券交易所（以 下简称"深交所"）出具本项目发行保荐书。 中泰证券及其保荐代表人根据《中华人民共和国公司法》（以下简称"《公司 法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、《上市公司证券发行 注册管理办法》（以下简称"《发行注册管理办法》"）、《发行证券的公司信息披露 内容与格式准则第 27 号——发行保荐书和发行保荐工作报告》《证券发行上市保 荐业务管理办法》等有关法律、法规和中国证监会、深圳证券交易所的有关规定， 诚实守信，勤勉尽责，严格按照依法制订的业务规则、行业执业 ...

投资者关系活动记录表 编号：2023-001 证券代码：300214 证券简称：日科化学 山东日科化学股份有限公司 山东日科化学股份有限公司投资者关系活动记录表 | 投资者关系活动类别 | □ 特定对象调研 □ 分析师会议 □ | | 媒体采访 | | --- | --- | --- | --- | | | √业绩说明会 □新闻发布会 □路演活动 | | | | | □现场参观 □其他 | | | | 参与单位名称 | 参与公司 年度业绩网上说明会的投资者 | 2022 | | | 及人员姓名 | | | | | 时间 | 2023 年 5 5 日 | 月 | | | 地点 | 深圳证券交易所"互动易"平台(http://irm.cninfo.com.cn) | | | | 上市公司接待人员姓名 | 董事长蒋荀先生，财务总监刘永强先生，副总经理、董事会秘书田志龙先生， | | | | | 独立董事朱明江先生，保荐代表人王宁华女士。 | | | | | 问：作为一个小股东，每天看到公司的成交量不到一千万、跌跌不休、 | | | | | 在边缘化时心就在滴血；公司 21 年增发的项目（已破发）都还没完工现在又 | ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥583,133,877.71, a decrease of 20.72% compared to ¥735,574,870.44 in the same period last year[5] - The net profit attributable to shareholders for Q1 2023 was ¥17,727,842.35, down 78.10% from ¥80,938,188.27 in the previous year[5] - The company reported a significant decrease in total profit, which was ¥21,499,163.10, down 78.85% from ¥101,674,709.53 in the same period last year[12] - The company’s diluted earnings per share for Q1 2023 was ¥0.04, a decrease of 76.47% compared to ¥0.17 in the previous year[5] - Total operating revenue for Q1 2023 was CNY 583.13 million, a decrease of 20.7% compared to CNY 735.57 million in Q1 2022[22] - Net profit for Q1 2023 was CNY 17.69 million, a decline of 78.1% from CNY 80.94 million in Q1 2022[23] - Earnings per share for Q1 2023 were CNY 0.04, compared to CNY 0.17 in Q1 2022[24] Cash Flow - The net cash flow from operating activities increased significantly by 366.33%, reaching ¥46,909,900.09 compared to ¥10,059,329.13 in Q1 2022[5] - The net cash flow from financing activities surged by 932.94% to ¥54,326,467.00, attributed to increased bank borrowings for project support[13] - The net cash flow from financing activities for the current period is ¥54,326,467.00, up from ¥5,259,412.82 in the previous period, representing an increase of about 935.5%[27] - Total cash inflow from operating activities decreased to ¥560,953,053.94 from ¥636,845,678.15, reflecting a decline of about 11.9%[25] - Cash outflow from operating activities also decreased to ¥514,043,153.85 from ¥626,786,349.02, indicating a reduction of approximately 17.9%[25] - The net cash flow from investment activities is negative at -¥113,453,896.17, compared to a positive ¥60,468,260.70 in the previous period[27] - Cash inflow from financing activities increased to ¥89,470,729.70 from ¥6,034,128.40, marking an increase of approximately 1,480.5%[27] - The ending balance of cash and cash equivalents decreased to ¥102,080,989.23 from ¥152,840,054.13, a decline of approximately 33.1%[27] Assets and Liabilities - The total assets at the end of Q1 2023 were ¥3,064,685,388.36, a slight increase of 0.58% from ¥3,046,987,882.64 at the end of the previous year[5] - The company's total liabilities amounted to CNY 519.06 million, slightly down from CNY 521.06 million in the previous quarter[23] - Total equity attributable to shareholders was CNY 2.55 billion, an increase from CNY 2.53 billion in the previous quarter[23] - Current assets decreased from 1,553,737,085.71 RMB to 1,215,790,275.39 RMB[19] - The total assets of the company reached CNY 3.06 billion, slightly up from CNY 3.05 billion in the previous quarter[23] Shareholder Information - The total number of common shareholders at the end of the reporting period is 14,778[14] - The largest shareholder, Zhao Dongri, holds 17.52% of shares, totaling 81,785,037 shares[14] Investments and Projects - The company plans to invest 950 million RMB in a project to produce 60,000 tons of lithium battery electrolyte raw materials annually[15] - A joint venture was established to invest in a project with an annual capacity of 600,000 tons of film and products, with a total investment of 152 million RMB[16] - The company has invested 6 million RMB to establish a joint venture for steam supply, with a registered capital of 20 million RMB[17] Research and Development - Research and development expenses rose by 117.75% to ¥11,338,619.86, reflecting the company's commitment to enhancing product offerings and adapting to market changes[12] - Research and development expenses increased to CNY 11.34 million, up 117.5% from CNY 5.21 million in the previous year[23]